370 related articles for article (PubMed ID: 28960561)
1. Clinical results of definitive chemoradiotherapy for cervical esophageal cancer: Comparison of failure pattern and toxicities between intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy.
Ito M; Kodaira T; Tachibana H; Tomita N; Makita C; Koide Y; Kato D; Abe T; Muro K; Tajika M; Niwa Y; Hasegawa Y
Head Neck; 2017 Dec; 39(12):2406-2415. PubMed ID: 28960561
[TBL] [Abstract][Full Text] [Related]
2. Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.
Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
Radiat Oncol; 2017 Aug; 12(1):131. PubMed ID: 28810885
[TBL] [Abstract][Full Text] [Related]
3. Comparison of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy, and volumetric-modulated arc therapy in the treatment of cervical esophageal carcinoma.
Yang H; Feng C; Cai BN; Yang J; Liu HX; Ma L
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27629865
[TBL] [Abstract][Full Text] [Related]
4. Comparative outcomes for three-dimensional conformal versus intensity-modulated radiation therapy for esophageal cancer.
Freilich J; Hoffe SE; Almhanna K; Dinwoodie W; Yue B; Fulp W; Meredith KL; Shridhar R
Dis Esophagus; 2015; 28(4):352-7. PubMed ID: 24635657
[TBL] [Abstract][Full Text] [Related]
5. Intensity-Modulated Radiotherapy versus Three-Dimensional Conformal Radiotherapy in Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: Comparison of Survival Outcomes and Toxicities.
Chen NB; Qiu B; Zhang J; Qiang MY; Zhu YJ; Wang B; Guo JY; Cai LZ; Huang SM; Liu MZ; Li Q; Hu YH; Li QW; Liu H
Cancer Res Treat; 2020 Jan; 52(1):31-40. PubMed ID: 31048664
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of intensity-modulated radiotherapy versus conventional radiotherapy for hypopharyngeal cancer.
Mok G; Gauthier I; Jiang H; Huang SH; Chan K; Witterick IJ; O'Sullivan B; Waldron JN; Bayley AJ; Cho BC; Cummings BJ; Dawson LA; Hope AJ; Kim JJ; Ringash J
Head Neck; 2015 May; 37(5):655-61. PubMed ID: 24590756
[TBL] [Abstract][Full Text] [Related]
7. Effect of Intensity Modulated Radiation Therapy With Concurrent Chemotherapy on Survival for Patients With Cervical Esophageal Carcinoma.
McDowell LJ; Huang SH; Xu W; Che J; Wong RKS; Brierley J; Kim J; Cummings B; Waldron J; Bayley A; Hansen A; Witterick I; Ringash J
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):186-195. PubMed ID: 28258892
[TBL] [Abstract][Full Text] [Related]
8. Comparison of xerostomia incidence after three-dimensional conformal radiation therapy and contralateral superficial lobe parotid-sparing intensity-modulated radiotherapy for oropharyngeal and hypopharyngeal cancer.
Kawamoto T; Nihei K; Nakajima Y; Kito S; Sasai K; Karasawa K
Auris Nasus Larynx; 2018 Oct; 45(5):1073-1079. PubMed ID: 29397249
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for stage I-II natural killer/T-cell lymphoma nasal type: dosimetric and clinical results.
Shen Q; Ma X; Hu W; Chen L; Huang J; Guo Y
Radiat Oncol; 2013 Jun; 8():152. PubMed ID: 23800149
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Toxicity Between Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy for Locally Advanced Non-small-cell Lung Cancer.
Ling DC; Hess CB; Chen AM; Daly ME
Clin Lung Cancer; 2016 Jan; 17(1):18-23. PubMed ID: 26303127
[TBL] [Abstract][Full Text] [Related]
11. Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer.
Lin SH; Wang L; Myles B; Thall PF; Hofstetter WL; Swisher SG; Ajani JA; Cox JD; Komaki R; Liao Z
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1078-85. PubMed ID: 22867894
[TBL] [Abstract][Full Text] [Related]
12. Comparison of survival, acute toxicities, and dose-volume parameters between intensity-modulated radiotherapy with or without internal target volume delineation method and three-dimensional conformal radiotherapy in cervical cancer patients: A retrospective and propensity score-matched analysis.
Liang YQ; Feng SQ; Xie WJ; Jiang QZ; Yang YF; Luo R; Kidd EA; Zhai TT; Xie LX
Cancer Med; 2022 Jan; 11(1):151-165. PubMed ID: 34821082
[TBL] [Abstract][Full Text] [Related]
13. [The efficacy and safety of high dose versus standard dose radiotherapy in concurrent chemoradiotherapy for patients with esophageal squamous cell carcinoma].
Ren XJ; Wang L; Han C; Liu LL
Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):135-139. PubMed ID: 30862144
[No Abstract] [Full Text] [Related]
14. Radiotherapy modality as a predictor of survival in hypopharyngeal cancer.
Kılıç S; Kılıç SS; Hsueh WD; Eloy JA; Baredes S; Woo Park RC; Mahmoud O
Head Neck; 2018 Nov; 40(11):2441-2448. PubMed ID: 30306665
[TBL] [Abstract][Full Text] [Related]
15. Intensity-modulated radiotherapy for cervical esophageal squamous cell carcinoma without hypopharyngeal invasion: dose distribution and clinical outcome.
Ishida Y; Sakanaka K; Fujii K; Itasaka S; Mizowaki T
J Radiat Res; 2019 Jul; 60(4):517-526. PubMed ID: 31083715
[TBL] [Abstract][Full Text] [Related]
16. Comparison of dosimetric parameters and acute toxicity of intensity-modulated and three-dimensional radiotherapy in patients with cervix carcinoma: A randomized prospective study.
Naik A; Gurjar OP; Gupta KL; Singh K; Nag P; Bhandari V
Cancer Radiother; 2016 Jul; 20(5):370-6. PubMed ID: 27368915
[TBL] [Abstract][Full Text] [Related]
17. Reduced toxicity with three-dimensional conformal radiotherapy or intensity-modulated radiotherapy compared with conventional two-dimensional radiotherapy for esophageal squamous cell carcinoma: a secondary analysis of data from four prospective clinical trials.
Deng JY; Wang C; Shi XH; Jiang GL; Wang Y; Liu Y; Zhao KL
Dis Esophagus; 2016 Nov; 29(8):1121-1127. PubMed ID: 26663710
[TBL] [Abstract][Full Text] [Related]
18. Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy.
Goenka A; Magsanoc JM; Pei X; Schechter M; Kollmeier M; Cox B; Scardino PT; Eastham JA; Zelefsky MJ
Eur Urol; 2011 Dec; 60(6):1142-8. PubMed ID: 21855208
[TBL] [Abstract][Full Text] [Related]
19. Intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical hysterectomy for uterine cervical cancer: comparison of outcomes, complications, and dose-volume histogram parameters.
Isohashi F; Mabuchi S; Yoshioka Y; Seo Y; Suzuki O; Tamari K; Yamashita M; Unno H; Kinose Y; Kozasa K; Sumida I; Otani Y; Kimura T; Ogawa K
Radiat Oncol; 2015 Aug; 10():180. PubMed ID: 26300325
[TBL] [Abstract][Full Text] [Related]
20. Comparison of intensity-modulated radiotherapy vs 3-dimensional conformal radiotherapy for patients with non-metastatic esophageal squamous cell carcinoma receiving definitive concurrent chemoradiotherapy: A population-based propensity-score-matched analysis.
Li CC; Chen CY; Chien CR
Medicine (Baltimore); 2018 Jun; 97(22):e10928. PubMed ID: 29851829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
